| Samuel David Patrick Mcelroy, MD | |
|
4451 Paulsen St, Savannah, Savannah, GA 31405-3664 | |
| (912) 350-7500 | |
| (912) 350-7735 |
| Full Name | Samuel David Patrick Mcelroy |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine |
| Experience | 14 Years |
| Location | 4451 Paulsen St, Savannah, Georgia |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1023302544 | NPI | - | NPPES |
| 003137659B | Medicaid | GA | |
| P01366532 | Other | GA | RAILROAD MEDICARE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | 072319 (Georgia) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Amedisys Home Health | Savannah, GA | Home health agency |
| Kindred At Home | Savannah, GA | Home health agency |
| Memorial University Medical Center | Savannah, GA | Hospital |
| Candler Hospital | Savannah, GA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Savannah Primary Care Associates Llc | 4688935760 | 46 |
News Archive
The 2015 MacLean Center Prize in Clinical Ethics and Health Outcomes, a $50,000 award, will be presented to Laura Roberts, MD, MA, a graduate of the University of Chicago Pritzker School of Medicine, who is chair of the Department of Psychiatry and Behavioral Sciences at the Stanford University School of Medicine and an internationally recognized scholar in bioethics, psychiatry, medicine and medical education.
Researchers at Karolinska Institutet in Sweden have managed to synthesise lung surfactant, a drug used in the care of preterm babies, by mimicking the production of spider silk.
Well, its probable (although not certain) that, within two or three decades, the Social Security trust fund will be exhausted, leaving the system unable to pay the full benefits specified by current law. So the plan is to avoid cuts in future benefits by committing right now to ... cuts in future benefits. Huh? O.K., you can argue that the adjustment to an aging population would be smoother if we commit to a glide path of benefit cuts now. On the other hand, by moving too soon we might lock in benefit cuts that turn out not to have been necessary.
Scientists at Johns Hopkins have turned their view of osteoarthritis inside out. Literally. Instead of seeing the painful degenerative disease as a problem primarily of the cartilage that cushions joints, they now have evidence that the bone underneath the cartilage is also a key player and exacerbates the damage.
Biodel Inc. today reported results of preclinical tests which demonstrated the potential of the company's glucose-regulated or "smart" basal insulin product candidate, BIOD620, to release insulin proportionally in response to changing glucose conditions. In an oral presentation today at the 37th Annual Meeting and Exposition of the Controlled Release Society in Portland, Oregon, Nandini Kashyap, director of novel drug delivery at Biodel, described results of in vitro and in vivo studies with diabetic pigs which compared the use of BIOD620 to Lantus® (insulin glargine).
› Verified 3 days ago
| Entity Name | Mppg Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1033131172 PECOS PAC ID: 7012829351 Enrollment ID: O20040223000338 |
News Archive
The 2015 MacLean Center Prize in Clinical Ethics and Health Outcomes, a $50,000 award, will be presented to Laura Roberts, MD, MA, a graduate of the University of Chicago Pritzker School of Medicine, who is chair of the Department of Psychiatry and Behavioral Sciences at the Stanford University School of Medicine and an internationally recognized scholar in bioethics, psychiatry, medicine and medical education.
Researchers at Karolinska Institutet in Sweden have managed to synthesise lung surfactant, a drug used in the care of preterm babies, by mimicking the production of spider silk.
Well, its probable (although not certain) that, within two or three decades, the Social Security trust fund will be exhausted, leaving the system unable to pay the full benefits specified by current law. So the plan is to avoid cuts in future benefits by committing right now to ... cuts in future benefits. Huh? O.K., you can argue that the adjustment to an aging population would be smoother if we commit to a glide path of benefit cuts now. On the other hand, by moving too soon we might lock in benefit cuts that turn out not to have been necessary.
Scientists at Johns Hopkins have turned their view of osteoarthritis inside out. Literally. Instead of seeing the painful degenerative disease as a problem primarily of the cartilage that cushions joints, they now have evidence that the bone underneath the cartilage is also a key player and exacerbates the damage.
Biodel Inc. today reported results of preclinical tests which demonstrated the potential of the company's glucose-regulated or "smart" basal insulin product candidate, BIOD620, to release insulin proportionally in response to changing glucose conditions. In an oral presentation today at the 37th Annual Meeting and Exposition of the Controlled Release Society in Portland, Oregon, Nandini Kashyap, director of novel drug delivery at Biodel, described results of in vitro and in vivo studies with diabetic pigs which compared the use of BIOD620 to Lantus® (insulin glargine).
› Verified 3 days ago
| Entity Name | Savannah Primary Care Associates Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1477066355 PECOS PAC ID: 4688935760 Enrollment ID: O20180306002314 |
News Archive
The 2015 MacLean Center Prize in Clinical Ethics and Health Outcomes, a $50,000 award, will be presented to Laura Roberts, MD, MA, a graduate of the University of Chicago Pritzker School of Medicine, who is chair of the Department of Psychiatry and Behavioral Sciences at the Stanford University School of Medicine and an internationally recognized scholar in bioethics, psychiatry, medicine and medical education.
Researchers at Karolinska Institutet in Sweden have managed to synthesise lung surfactant, a drug used in the care of preterm babies, by mimicking the production of spider silk.
Well, its probable (although not certain) that, within two or three decades, the Social Security trust fund will be exhausted, leaving the system unable to pay the full benefits specified by current law. So the plan is to avoid cuts in future benefits by committing right now to ... cuts in future benefits. Huh? O.K., you can argue that the adjustment to an aging population would be smoother if we commit to a glide path of benefit cuts now. On the other hand, by moving too soon we might lock in benefit cuts that turn out not to have been necessary.
Scientists at Johns Hopkins have turned their view of osteoarthritis inside out. Literally. Instead of seeing the painful degenerative disease as a problem primarily of the cartilage that cushions joints, they now have evidence that the bone underneath the cartilage is also a key player and exacerbates the damage.
Biodel Inc. today reported results of preclinical tests which demonstrated the potential of the company's glucose-regulated or "smart" basal insulin product candidate, BIOD620, to release insulin proportionally in response to changing glucose conditions. In an oral presentation today at the 37th Annual Meeting and Exposition of the Controlled Release Society in Portland, Oregon, Nandini Kashyap, director of novel drug delivery at Biodel, described results of in vitro and in vivo studies with diabetic pigs which compared the use of BIOD620 to Lantus® (insulin glargine).
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Samuel David Patrick Mcelroy, MD 4451 Paulsen St, Savannah, Savannah, GA 31405-3664 Ph: (912) 350-7500 | Samuel David Patrick Mcelroy, MD 4451 Paulsen St, Savannah, Savannah, GA 31405-3664 Ph: (912) 350-7500 |
News Archive
The 2015 MacLean Center Prize in Clinical Ethics and Health Outcomes, a $50,000 award, will be presented to Laura Roberts, MD, MA, a graduate of the University of Chicago Pritzker School of Medicine, who is chair of the Department of Psychiatry and Behavioral Sciences at the Stanford University School of Medicine and an internationally recognized scholar in bioethics, psychiatry, medicine and medical education.
Researchers at Karolinska Institutet in Sweden have managed to synthesise lung surfactant, a drug used in the care of preterm babies, by mimicking the production of spider silk.
Well, its probable (although not certain) that, within two or three decades, the Social Security trust fund will be exhausted, leaving the system unable to pay the full benefits specified by current law. So the plan is to avoid cuts in future benefits by committing right now to ... cuts in future benefits. Huh? O.K., you can argue that the adjustment to an aging population would be smoother if we commit to a glide path of benefit cuts now. On the other hand, by moving too soon we might lock in benefit cuts that turn out not to have been necessary.
Scientists at Johns Hopkins have turned their view of osteoarthritis inside out. Literally. Instead of seeing the painful degenerative disease as a problem primarily of the cartilage that cushions joints, they now have evidence that the bone underneath the cartilage is also a key player and exacerbates the damage.
Biodel Inc. today reported results of preclinical tests which demonstrated the potential of the company's glucose-regulated or "smart" basal insulin product candidate, BIOD620, to release insulin proportionally in response to changing glucose conditions. In an oral presentation today at the 37th Annual Meeting and Exposition of the Controlled Release Society in Portland, Oregon, Nandini Kashyap, director of novel drug delivery at Biodel, described results of in vitro and in vivo studies with diabetic pigs which compared the use of BIOD620 to Lantus® (insulin glargine).
› Verified 3 days ago
Florin C Georgescu, M. D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 500 E 66th St, Savannah, GA 31405 Phone: 912-356-5643 Fax: 912-356-9712 | |
James A Daly Iii, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 340 Hodgson Ct, Suite 2, Savannah, GA 31406 Phone: 912-629-2290 Fax: 912-629-2291 | |
Elizabeth Florence Cornell, DO Internal Medicine Medicare: May Accept Medicare Assignments Practice Location: 6602 Waters Ave Bldg A, Savannah, GA 31406 Phone: 912-350-6000 Fax: 912-350-6001 | |
Dr. Kinhtu Lien, MD Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 4700 Waters Ave, Savannah, GA 31404 Phone: 912-350-7573 | |
Dr. Barry James Krakow, MD Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 211 Early St, Savannah, GA 31405 Phone: 505-238-7519 | |
Dr. John David Northup, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 12345 Mercy Blvd, Savannah, GA 31419 Phone: 912-927-3046 Fax: 912-925-0597 |